Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy

New England Journal of Medicine

Volumn 366, Issue 25, 2012, Pages 2345-2357

  Schoen, Robert E ^a,b,c   Pinsky, Paul F ^d   Weissfeld, Joel L ^b,c   Yokochi, Lance A ^h   Church, Timothy ⁱ   Laiyemo, Adeyinka O ^j   Bresalier, Robert ^l   Andriole, Gerald L ^m   Buys, Saundra S ⁿ   Crawford, E David ^o   Fouad, Mona N ^p   Isaacs, Claudine ^k   Johnson, Christine C ^q   Reding, Douglas J ^r   O'Brien, Barbara ^f   Carrick, Danielle M ^f   Wright, Patrick ^g   Riley, Thomas L ^g   Purdue, Mark P ^d   Izmirlian, Grant ^d   Kramer, Barnett S ^d   Miller, Anthony B ^s   Gohagan, John K ^e   Prorok, Philip C ^d   Berg, Christine D ^d   more..

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f WESTAT   (United States)

^g INFORMATION MANAGEMENT SERVICES INC   (United States)

^h PACIFIC HEALTH RESEARCH AND EDUCATION INSTITUTE   (United States)

ⁱ UNIVERSITY OF MINNESOTA   (United States)

^j HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^k GEORGETOWN UNIVERSITY   (United States)

^l UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^m WASHINGTON UNIVERSITY   (United States)

ⁿ UNIVERSITY OF UTAH   (United States)

^o UNIVERSITY OF COLORADO   (United States)

^p UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^q HENRY FORD HEALTH SYSTEM   (United States)

^r MARSHFIELD CLINIC   (United States)

^s UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DEVICE INFECTION; ENDOSCOPIC CONTAMINATION; FALSE POSITIVE RESULT; FEMALE; FLEXIBLE SIGMOIDOSCOPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SIGMOIDOSCOPY;

EID: 84862583882     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1114635     Document Type: Article

References (41)

1. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011;61:212-36.
2. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7. (Pubitemid 26400242)
3. Kronborg O, Jorgensen OD, Fenger C, Rasmussen M. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol 2004;39:846-51. (Pubitemid 39215455)
4. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999;91:434-7. (Pubitemid 29128279)
5. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7. (Pubitemid 32162983)
6. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): an update. Am J Gastroenterol 2008;103:1541-9. (Pubitemid 351813919)
7. Hol L, van Leerdam ME, van Ballegooijen M, et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010;59:62-8.
8. Segnan N, Senore C, Andreoni B, et al. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology 2007;132:2304-12. (Pubitemid 46900821)
9. Quintero E, Castells A, Bujanda L, et al. Colonoscopy vs. fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 2012;366:697-706.
10. Weissfeld JL, Schoen RE, Pinsky PF, et al. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. J Natl Cancer Inst 2005;97:989-97.
11. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010;375:1624-33.
12. Segnan N, Armaroli P, Bonelli L, et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian randomized controlled trial - SCORE. J Natl Cancer Inst 2011;103:1310-22.
13. Hoff G, Grotmol T, Skovlund E, Bretthauer M. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ 2009;338:b1846.
14. Weissfeld JL, Schoen RE, Pinsky PF, et al. Flexible sigmoidoscopy in the randomized Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: added yield from a second screening examination. J Natl Cancer Inst 2012;104:280-9.
15. Prorok PC, Andriole GL, Bresalier RS, et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000;21:Suppl:273S-309S.
16. Simpson NK, Johnson CC, Ogden SL, et al. Recruitment strategies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: the first six years. Control Clin Trials 2000;21:Suppl:356S-378S.
17. Fleming ID, Cooper JS, Henson DE, et al. AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven, 1997.
18. Miller AB, Yurgalevitch S, Weissfeld JL. Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000;21:Suppl:400S-406S.
19. Schoen RE, Pinsky PF, Weissfeld JL, et al. Utilization of surveillance colonoscopy in community practice. Gastroenterology 2010;138:73-81.
20. Pinsky PF, Schoen RE, Weissfeld JL, et al. The yield of surveillance colonoscopy by adenoma history and time to examination. Clin Gastroenterol Hepatol 2009;7:86-92.
21. Ahlbom A. Biostatistics for epidemiologists. Boca Raton, FL: Lewis, 1993.
22. Izmirlian G. Estimation of the relative risk following group sequential procedure based upon the weighted log-rank statistic. Ithaca, NY: Cornell University Library, February 2011 (http://arxiv.org/abs/1102.5088).
23. DeMets DL, Lan G. The alpha spending function approach to interim data analyses. Cancer Treat Res 1995;75:1-27.
24. Lin DY, Yao Q, Ying ZL. A general theory on stochastic curtailment for censored survival data. J Am Stat Assoc 1999;94:510-21.
25. SAS/STAT, version 9. Cary, NC: SAS Institute, 2010.
26. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing, 2010.
27. Croswell JM, Kramer BS, Kreimer AR, et al. Cumulative incidence of false-positive results in repeated, multimodal cancer screening. Ann Fam Med 2009;7:212-22.
28. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008;134:1570-95. (Pubitemid 351615355)
29. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008;149:627-37.
30. Vital signs: colorectal cancer screening, incidence, and mortality - United States, 2002-2010. MMWR Morb Mortal Wkly Rep 2011;60:884-9.
31. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009;150:1-8.
32. Singh H, Nugent Z, Demers AA, Kliewer EV, Mahmud SM, Bernstein CN. The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology 2010;139:1128-37.
33. Singh H, Nugent Z, Mahmud SM, Demers AA, Bernstein CN. Predictors of colorectal cancer after negative colonoscopy: a population-based study. Am J Gastroenterol 2010;105:663-73.
34. Lakoff J, Paszat LF, Saskin R, Rabeneck L. Risk of developing proximal vs. distal colorectal cancer after a negative colonoscopy: a population-based study. Clin Gastroenterol Hepatol 2008;6:1117-21.
35. Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M. Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med 2011;154:22-30.
36. Baxter NN, Warren J, Barrett MJ, Stukel T, Doria-Rose VR. The association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. Gastroenterology 2011;140:Suppl:S74-S75.
37. Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal cancers not detected by screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Gastrointest Endosc 2012;75:612-20.
38. Minoo P, Zlobec I, Peterson M, Terracciano L, Lugli A. Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles. Int J Oncol 2010;37:707-18.
39. Leggett B, Whitehall V. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 2010;138:2088-100.
40. Deng G, Kakar S, Tanaka H, et al. Proximal and distal colorectal cancers show distinct gene-specific methylation profiles and clinical and molecular characteristics. Eur J Cancer 2008;44:1290-301.
41. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71. [Erratum, N Engl J Med 1993;329:672.] (Pubitemid 23131388)